Page 22 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

20
Chapter 1
References
1 Bradley P, Guntinas-Lichius O. Salivary Gland Disorders and Diseases: Diagnosis and Management. 1st ed. Stuttgart and New York: Thieme Publishing Group; 2011.
2 Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg 2013; 51: 399-403
3 El-Naggar A, Chan J, Takata T, et al. WHO Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. 4th ed. Lyon: IARC Press; 2017.
4 Kato S, Elkin S, Schwaederle M, et al. Genomic landscape of salivary gland tumors. Oncotarget 2015; 6: 25631-25645
5 de Ridder M, Balm AJM, Smeele LE, et al. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010). Cancer Epidemiol 2015; 39: 14-20
6 Bjørndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2011; 47: 677-682
7 Spiro R. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8: 177-184
8 Loutfi I, Nair M, Ebrahim A. Salivary Gland Scintigraphy: The Use of Semiquantitative Analysis for Uptake and Clearance. J Nucl Med Technol 2003; 31: 81-85
9 Klein Nulent TJW, Valstar MH, de Keizer B, et al. Physiological distribution of PSMA-ligand in salivary and seromucous glands of the head and neck on PET/CT. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125: 478-486